INTERNATIONAL PATENT: PROTAGONIST THERAPEUTICS, INC. FILES APPLICATION FOR "DUAL- AND TRI-AGONIST COMPOUNDS FOR OBESITY & T2DM"

GENEVA, March 24 -- PROTAGONIST THERAPEUTICS, INC. (7707 Gateway BoulevardSuite 140Newark, California 94560) filed a patent application (PCT/US2025/045936) for "DUAL- AND TRI-AGONIST COMPOUNDS FOR OBESITY & T2DM" on Sep 11, 2025. With publication no. WO/2026/060110, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BHANDARI, Ashok (c/o Protagonist Therapeutics, Inc.7707 Gateway BoulevardSuite 140Newark, California 94560), BOURNE, Gregory Thomas (c/o Protagonist Therapeutics, Inc.7707 Gateway BoulevardSuite 140Newark, Califo...